There is great interest in evaluating the link between hypercalcemia and prognosis in ccRCC by researching the genes that influence calcium levels.
The microbiome could have a role in the diagnosis of PrCa.
The combination of ENCO and BINI had greater antitumor activity against mCRC cells with the BRAF V600E mutation.
Patients treated with ADT for prostate cancer had a higher hazard ratio for developing Alzheimer disease than those who did not receive this therapy.
In this study, preexisting immunity to the viral vector used for the vaccine led to poor responses, as the product was neutralized.
Updated guidelines advised against performing cytoreductive nephrectomy in poor-risk patients.
Although there have been significant advancements in the treatment of prostate cancer with medications, radiation, surgery and/or brachytherapy, there continue to be concerns about posttreatment side effects.
CD33 positivity and MPC-1 negativity appear to be associated with worse outcomes in patients with multiple myeloma treated with bortezomib as induction therapy.
There appears to be accumulating evidence to support the routine use of busulfan plus melphalan as a conditioning regimen.
As CML transitions across its 3 phases, the number of additional chromosomal abnormalities appears to increase.
